GenesisTissue is among the 21 companies and 15 researchers to be awarded Proof of Concept and Early-Stage Capital and Retention grants through OEDIT’s Advanced Industries Accelerator Program.
Follow us on LinkedIn to stay up to date on our latest developments and milestones!